Bank of Montreal Can increased its holdings in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 6.9% in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 10,603 shares of the software maker’s stock after buying an additional 689 shares during the quarter. Bank of Montreal Can’s holdings in Allscripts Healthcare Solutions were worth $135,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MDRX. Thrivent Financial For Lutherans boosted its position in Allscripts Healthcare Solutions by 255.4% in the first quarter. Thrivent Financial For Lutherans now owns 111,780 shares of the software maker’s stock worth $1,418,000 after purchasing an additional 80,330 shares during the last quarter. Neuburgh Advisers LLC boosted its position in Allscripts Healthcare Solutions by 4.1% in the first quarter. Neuburgh Advisers LLC now owns 12,070 shares of the software maker’s stock worth $153,000 after purchasing an additional 476 shares during the last quarter. Canada Pension Plan Investment Board boosted its position in Allscripts Healthcare Solutions by 12.0% in the first quarter. Canada Pension Plan Investment Board now owns 82,200 shares of the software maker’s stock worth $1,042,000 after purchasing an additional 8,800 shares during the last quarter. OppenheimerFunds Inc. boosted its position in Allscripts Healthcare Solutions by 9.4% in the first quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock worth $399,000 after purchasing an additional 2,701 shares during the last quarter. Finally, Credit Agricole S A purchased a new position in Allscripts Healthcare Solutions in the first quarter worth about $300,000.

MDRX has been the topic of several research reports. Leerink Swann cut Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $15.00 to $13.00 in a research report on Monday, June 19th. Cantor Fitzgerald reissued a “neutral” rating and issued a $13.00 target price on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Piper Jaffray Companies reissued a “hold” rating and issued a $14.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, July 21st. BidaskClub raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, June 24th. Finally, Maxim Group reissued a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $14.63.

ILLEGAL ACTIVITY NOTICE: This report was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/allscripts-healthcare-solutions-inc-mdrx-shares-bought-by-bank-of-montreal-can/1550847.html.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) traded down 2.25% on Friday, hitting $13.05. The stock had a trading volume of 2,113,709 shares. The company’s 50 day moving average is $12.75 and its 200-day moving average is $12.32. The stock’s market cap is $2.36 billion. Allscripts Healthcare Solutions, Inc. has a 12 month low of $9.80 and a 12 month high of $13.70.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, August 3rd. The software maker reported $0.11 EPS for the quarter, missing the consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The firm had revenue of $426.10 million during the quarter, compared to the consensus estimate of $424.94 million. During the same period in the prior year, the business earned $0.14 earnings per share. Allscripts Healthcare Solutions’s quarterly revenue was up 10.2% compared to the same quarter last year. Analysts forecast that Allscripts Healthcare Solutions, Inc. will post $0.62 EPS for the current year.

Allscripts Healthcare Solutions Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.